Total Payments
$2,106
2024 Payments
$127.31
Companies
5
Transactions
21
Medicare Patients
335
Medicare Billing
$47,151

Payment Breakdown by Category

Consulting$1,500 (71.2%)
Food & Beverage$605.65 (28.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,500 1 71.2%
Food and Beverage $605.65 20 28.8%

Top Paying Companies

Company Total Records Latest Year
QIAGEN, LLC $1,500 1 $0 (2023)
Celgene Corporation $315.02 10 $0 (2018)
Amgen Inc. $127.31 2 $0 (2024)
AbbVie, Inc. $122.05 6 $0 (2017)
Regeneron Healthcare Solutions, Inc. $41.27 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $127.31 2 Amgen Inc. ($127.31)
2023 $1,500 1 QIAGEN, LLC ($1,500)
2019 $17.08 1 Regeneron Healthcare Solutions, Inc. ($17.08)
2018 $181.62 5 Celgene Corporation ($157.43)
2017 $279.64 12 Celgene Corporation ($157.59)

All Payment Transactions

21 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/12/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $106.53 General
Category: Inflammation
05/31/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $20.78 General
Category: Inflammation
01/30/2023 QIAGEN, LLC Consulting Fee Cash or cash equivalent $1,500.00 General
05/13/2019 Regeneron Healthcare Solutions, Inc. KEVZARA (Biological) Food and Beverage In-kind items and services $17.08 General
Category: INFLAMMATION AND IMMUNOLOGY
04/30/2018 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Dermatology
04/13/2018 Regeneron Healthcare Solutions, Inc. KEVZARA SARILUMAB INJECTION (Biological) Food and Beverage In-kind items and services $24.19 General
Category: INFLAMMATION AND IMMUNOLOGY
01/31/2018 Celgene Corporation Food and Beverage In-kind items and services $9.51 General
01/19/2018 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $15.48 General
Category: Dermatology
01/10/2018 Celgene Corporation Food and Beverage In-kind items and services $7.44 General
12/03/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $8.39 General
Category: Immunology
11/17/2017 AbbVie, Inc. Food and Beverage In-kind items and services $18.74 General
11/03/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $78.63 General
Category: Immunology
10/25/2017 Celgene Corporation Food and Beverage In-kind items and services $6.20 General
08/30/2017 Celgene Corporation Food and Beverage In-kind items and services $9.31 General
08/23/2017 Celgene Corporation Food and Beverage In-kind items and services $4.30 General
07/26/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $6.11 General
Category: Immunology
07/12/2017 Celgene Corporation Food and Beverage In-kind items and services $5.76 General
06/14/2017 Celgene Corporation Food and Beverage In-kind items and services $7.12 General
05/17/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $8.12 General
Category: Immunology
05/17/2017 AbbVie, Inc. Humira (Biological) Food and Beverage In-kind items and services $2.06 General
Category: Immunology
04/20/2017 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $124.90 General
Category: Dermatology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 106 145 $100,063 $14,713
2022 4 94 146 $100,346 $14,542
2021 2 63 96 $54,580 $10,235
2020 3 72 117 $48,985 $7,660
Total Patients
335
Total Services
504
Medicare Billing
$47,151
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 40 51 $39,960 $6,226 15.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 42 65 $32,825 $5,293 16.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $18,718 $2,019 10.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 16 $8,560 $1,176 13.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 44 79 $39,895 $6,131 15.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 28 40 $27,200 $5,543 20.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 11 11 $15,838 $2,057 13.0%
20610 Aspiration and/or injection of fluid from large joint Office 2022 11 16 $17,413 $810.73 4.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 29 40 $26,720 $5,548 20.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 34 56 $27,860 $4,686 16.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 24 49 $22,050 $3,267 14.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 33 51 $22,695 $3,108 13.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 15 17 $4,240 $1,285 30.3%

About Dr. Shereen Mahmood, M.D

Dr. Shereen Mahmood, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1447693007.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shereen Mahmood, M.D has received a total of $2,106 in payments from pharmaceutical and medical device companies, with $127.31 received in 2024. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,500).

As a Medicare-enrolled provider, Mahmood has provided services to 335 Medicare beneficiaries, totaling 504 services with total Medicare billing of $47,151. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

Products in Payments

  • Otezla (Drug) $371.91
  • Humira (Biological) $103.31
  • KEVZARA SARILUMAB INJECTION (Biological) $24.19
  • TAVNEOS (Drug) $20.78
  • KEVZARA (Biological) $17.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Manhasset